Shares of major US health insurers fell again on Wednesday, November 18. UnitedHealth Group (NYSE: UNH) ended the day 10.21% lower, according to FXStreet. FXStreet said it was the second straight session of losses for managed care stocks and that UnitedHealth alone made up roughly two-fifths of the Dow's decline. Humana (NYSE: HUM) dropped about 13%. The figures come from a market commentary published November 19 by Equity Insider, which gives no reason for the declines.
A separate regulatory proposal
The industry is also facing a new federal proposal. On November 16, the Centers for Medicare & Medicaid Services unveiled a rule called Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH. According to Becker's Hospital Review, the agency hopes it will save close to $90 billion in federal spending over ten years across Medicare, Medicaid and the ACA marketplace.
For insurers, the most relevant part is a renewed push for oversight. Becker's Payer Issues reported that the government is once again trying to gain more power to examine Medicare Advantage plans and reclaim money it overpaid. Members of the public can comment until January 19, 2027. Humana has challenged a similar measure before. It went to court over an earlier CMS audit rule for Medicare Advantage in September 2023, Becker's Hospital Review reported. None of the reports cited in the commentary connects the proposal to this week's share moves.
Market backdrop
The insurer losses pulled down the blue-chip index. The Dow Jones Industrial Average closed 561.25 points, or 1.11%, lower, according to CNBC. The S&P 500 slipped 0.23% to 7,323.63. That was its fifth decline in a row, the longest such run since June. The Nasdaq Composite bucked the trend with a 0.42% gain.
Investors were also digesting minutes from the Federal Reserve's October meeting, which came out on Wednesday afternoon. Reports on the minutes said nearly every official judged more rate increases likely appropriate. Governor Christopher Waller told CNBC that a half-point move in December may be needed. The commentary, citing the Fed's calendar, said the central bank's next decision is set for December 9.


